Genetic Technologies Announces Financial Results for First Fiscal Quarter Ended September 30, 2013
October 31, 2013 14:23 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Oct 31, 2013) - -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE)
Record number of BREVAGen™ samples received...
Genetic Technologies Announces Temporary Corporate Restructure
October 15, 2013 06:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Oct 15, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) wishes to inform the Market that Chief Executive Officer, Ms. Alison Mew, will be...
Genetic Technologies Announces Record Quarter for BREVAGen(TM)
October 01, 2013 06:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Oct 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) announced that a further record number of BREVAGen™ test samples were received...
ImmunAid Limited Commences Second Round Fundraising Program
September 26, 2013 07:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Sep 26, 2013) - As foreshadowed in its ASX announcement dated 10 July 2013, Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to report that...
Achaogen Announces Agreement With FDA on a Special Protocol Assessment for a Phase 3 Clinical Trial of Plazomicin to Treat Infections Caused by Carbapenem-Resistant Enterobacteriaceae (CRE)
September 23, 2013 06:00 ET
|
Achaogen
SOUTH SAN FRANCISCO, CA--(Marketwired - Sep 23, 2013) - Achaogen, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol...
Aquilo Capital Management Submits Open Letter to the Board of Directors and Fellow Shareholders of Astex Pharmaceuticals
September 09, 2013 05:00 ET
|
Aquilo Capital Management
SAN FRANCISCO, CA--(Marketwired - Sep 9, 2013) -
Dear members of the Board and fellow shareholders of Astex Pharmaceuticals,
We are the Managing General Partner and Portfolio...
Genetic Technologies Receives Certification for New York State
August 30, 2013 07:00 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 30, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that it has received its Clinical Laboratory Permit from the New...
Alchemia Reports Record Fondaparinux Quarterly Profit Share
August 20, 2013 06:00 ET
|
Alchemia
BRISBANE, AUSTRALIA--(Marketwired - Aug 20, 2013) -
A$3.9m profit share for quarter ending 30 June 2013
Total Alchemia fondaparinux profit share of A$9.6m...
Vital Therapies, Inc. Receives Orphan Designation in Europe
August 05, 2013 05:00 ET
|
Vital Therapies
SAN DIEGO, CA--(Marketwired - Aug 5, 2013) - Vital Therapies®, Inc., a biopharmaceutical company focused on developing a cell-based therapy targeting the treatment of acute liver failure,...
Genetic Technologies Announces Financing and Intended Use of Proceeds
August 01, 2013 05:15 ET
|
Genetic Technologies
MELBOURNE, AUSTRALIA--(Marketwired - Aug 1, 2013) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE)
Finalised private placement of shares to domestic and...